Erik Mordukhay
Adult Health · Brooklyn, NYNPI 1851464853
Payments from drug & device makers
Across 66 payments — averaging $24.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$314
- Celltrion, Inc.$300
- Novo Nordisk$220
- Astellas Pharma US Inc$116
- Bayer$104
- Amgen$91
- plus $504 from 13 others
What the payments were for
- Speaking & faculty fees$473%
- Food & beverage$1,30279%
- Gifts$30018%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 17 | $314 |
| Celltrion, Inc. | 1 | $300 |
| Novo Nordisk | 10 | $220 |
| Astellas Pharma US Inc | 4 | $116 |
| Bayer | 4 | $104 |
| Amgen(2 entities) | 5 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $76 |
| Pfizer | 3 | $70 |
| Amarin Pharma, Inc. | 3 | $59 |
| Ardelyx, Inc. | 2 | $57 |
| BD | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| AbbVie | 2 | $36 |
| Boehringer Ingelheim | 1 | $25 |
| Corcept Therapeutics | 1 | $25 |
| Shield Therapeutics Inc | 1 | $24 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Cumberland Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$1,649 in reported general payments places this provider in the 75th percentile of 3,828 adult health providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 113 | $113,108 |
| MounjaroTirzepatide | 109 | $112,987 |
| OzempicSemaglutide | 114 | $111,019 |
| JardianceEmpagliflozin | 156 | $101,749 |
| LinzessLinaclotide | 183 | $96,958 |
| Diclofenac Sodium | 155 | $84,526 |
| JanuviaSitagliptin Phosphate | 101 | $62,115 |
| KerendiaFinerenone | 64 | $46,103 |
| CreonLipase/Protease/Amylase | 40 | $45,700 |
| EliquisApixaban | 70 | $39,477 |
| UbrelvyUbrogepant | 23 | $34,853 |
| Breo ElliptaFluticasone/Vilanterol | 79 | $30,213 |
| JanumetSitagliptin Phos/Metformin Hcl | 39 | $24,798 |
| LyricaPregabalin | 28 | $22,721 |
| XareltoRivaroxaban | 37 | $22,470 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $314 | $226,095222 claims |
| AbbVieLinzess, Creon, Ubrelvy, Synthroid | $36 | $180,434302 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta | $25 | $126,258205 claims |
| Novo NordiskOzempic | $220 | $111,019114 claims |
| PfizerEliquis, Lyrica | $70 | $62,19898 claims |
| BayerKerendia | $104 | $46,10364 claims |
| Astellas Pharma US IncMyrbetriq | $116 | $11,33421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,828 adult health providers in New York.
Other adult health in Brooklyn
- Huiwen YingBrooklyn$17K
- Joyce YeungBrooklyn$15K
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.